Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Astrazeneca Pharma India: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015
News Announcement

Astrazeneca Pharma India: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015

08-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Astrazeneca Pharma

Please find the enclosed letter of the Company as per the captioned subject for your reference.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan